TBPH- Theravance Biopharma, Inc.

Over the past 90 days, insiders at Theravance Biopharma, Inc. (TBPH) have been net sellers, shedding 13,314 shares worth roughly $227K on balance.

TBPH sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Samaha Eli	9.17M	$155.98M	-
CFO	Sawaf Aziz	131.9K	-	-
VP	Grimaud Brett A.	131.3K	-	-
VP	Miller Aine	96.7K	-	-
VP	Farnum Rhonda	89.1K	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 11, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,322	$9.99	$23,196.78	-0.7%	+1.0%	-23.2%
Jul 14, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,322	$9.84	$22,848.48	-0.7%	-6.2%	-4.3%
Jun 14, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,322	$10.69	$24,822.18	-0.7%	-5.6%	-17.6%
Jun 8, 2023	Farnum Rhonda51	SVP, Comm &Medical Affairs	Sell	1,790	$11.13	$19,922.70	-0.5%	-14.3%	-21.3%
May 15, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,322	$11.26	$26,145.72	-0.6%	-10.6%	-16.6%
Apr 14, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,323	$11.88	$27,597.24	-0.6%	-17.4%	-19.4%
Mar 14, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,323	$10.32	$23,973.36	-0.6%	-0.7%	-17.1%
Mar 9, 2023	Farnum Rhonda51	SVP, Comm &Medical Affairs	Sell	4,000	$10.20	$40,800.00	-1.1%	+9.0%	-15.9%
Mar 6, 2023	Graham Richard A71	SVP, Research &Development	Sell	2,323	$10.05	$23,346.15	-0.6%	+9.8%	-14.6%
Dec 14, 2022	Winningham Rick E64	Chief Executive Officer	Sell	50,000	$11.19	$559,500.00	-3.6%	-5.4%	-1.8%